Clinical Trial Update: Calcium Channel Blocker in Myotonic Dystrophy Type 1 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a calcium channel blocker for myotonic dystrophy type 1 is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Drugs mentioned

• Calcium channel blocker (calcium channel blocker)

Snippet

Sponsor: University of Rochester | Conditions: Myotonic Dystrophy 1 | Phase 1 | Status: NOT_YET_RECRUITING